My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 9 521 / DOI: 10.3332/ecancer.2015.521

Clinical Study

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent

Itraconazole, a common triazole anti-fungal drug in widespread clinical use, has evidence of clinical activity that is of interest in oncology. There is evidence that at the clinically relevant doses, itraconazole has potent anti-angiogenic activity, and that it can inhibit the Hedgehog signalling pathway and may also induce autophagic growth arrest. The evidence for these anticancer effects, in vitro, in vivo, and clinical are summarised, and the putative mechanisms of their action outlined. Clinical trials have shown that patients with prostate, lung, and basal cell carcinoma have benefited from treatment with itraconazole, and there are additional reports of activity in leukaemia, ovarian, breast, and pancreatic cancers. Given the evidence presented, a case is made that itraconazole warrants further clinical investigation as an anti-cancer agent. Additionally, based on the properties summarised previously, it is proposed that itraconazole may synergise with a range of other drugs to enhance the anti-cancer effect, and some of these possible combinations are presented in the supplementary materials accompanying this paper.

Keywords: Drug repurposing, itraconazole, Hedgehog pathway inhibition, ReDO project

Loading Article Metrics ... Please wait

Related articles

Conference Report: Highlights from the first International ecancer Conference on Oncology and Radiotherapy, 6–7 May 2016, Santiago, Chile

Abstract | Full Article | PDF | Spanish Published: 22 Jul 2016 / DOI: 10.3332/ecancer.2016.658

Special Issue: Integration of legal aspects and human rights approach in palliative care delivery—The Nyeri hospice model

Abstract | Full Article | PDF Published: 07 Jul 2016 / DOI: 10.3332/ecancer.2016.656

Special Issue: The Island Hospice model of palliative care

Abstract | Full Article | PDF Published: 07 Jul 2016 / DOI: 10.3332/ecancer.2016.654

Special Issue: Interventions geared towards strengthening the health system of Namibia through the integration of palliative care

Abstract | Full Article | PDF Published: 07 Jul 2016 / DOI: 10.3332/ecancer.2016.653

Special Issue: Best practices in developing a national palliative care policy in resource limited settings: lessons from five African countries

Abstract | Full Article | PDF Published: 07 Jul 2016 / DOI: 10.3332/ecancer.2016.652



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence